Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
Wilmot, Emma
Wilmot, Emma
Abstract
Since the introduction of real-time continuous glucose monitoring (CGM) systems more than 15 years ago and, more recently, flash glucose monitoring (Flash-GM), clinical studies have observed reductions in HbA1c , independent of insulin delivery method, with decreasing time spent in hypoglycaemia [1] and reduction in glycaemic variability [2]. CGM can improve quality of life and reduce diabetes-related distress [3], including fear of hypoglycaemia [4,5]. Despite these benefits, CGM has yet to be fully implemented as part of the standard of care for people living with Type 1 diabetes in England, and there is considerable variation in how it is funded through local payer organizations.
MIDER Authors
Citations
Altmetric:
Date
2018-06
Type
Article
Subject
Collections
Citation
Diabet Med. 2018 Jun 22. doi: 10.1111/dme.13766. [Epub ahead of print]
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
Author(s) Pre Print Version Only. 12 Month Embargo on Post. No PDF